JP2017502941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017502941A5 JP2017502941A5 JP2016538536A JP2016538536A JP2017502941A5 JP 2017502941 A5 JP2017502941 A5 JP 2017502941A5 JP 2016538536 A JP2016538536 A JP 2016538536A JP 2016538536 A JP2016538536 A JP 2016538536A JP 2017502941 A5 JP2017502941 A5 JP 2017502941A5
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- drug substance
- weight
- pharmaceutical formulation
- total weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361915606P | 2013-12-13 | 2013-12-13 | |
| US61/915,606 | 2013-12-13 | ||
| PCT/IB2014/066820 WO2015087283A1 (en) | 2013-12-13 | 2014-12-11 | Pharmaceutical dosage forms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019082147A Division JP6804585B2 (ja) | 2013-12-13 | 2019-04-23 | 医薬剤形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017502941A JP2017502941A (ja) | 2017-01-26 |
| JP2017502941A5 true JP2017502941A5 (enExample) | 2018-01-25 |
| JP6522619B2 JP6522619B2 (ja) | 2019-05-29 |
Family
ID=52146563
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538536A Active JP6522619B2 (ja) | 2013-12-13 | 2014-12-11 | 医薬剤形 |
| JP2019082147A Active JP6804585B2 (ja) | 2013-12-13 | 2019-04-23 | 医薬剤形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019082147A Active JP6804585B2 (ja) | 2013-12-13 | 2019-04-23 | 医薬剤形 |
Country Status (33)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105813635A (zh) | 2013-12-13 | 2016-07-27 | 诺华股份有限公司 | 药物剂型 |
| MA41611A (fr) * | 2015-02-23 | 2018-01-02 | Omthera Pharmaceuticals Inc | Préparations en milli-capsules comprenant des acides gras polyinsaturés libres |
| WO2019046167A1 (en) | 2017-08-30 | 2019-03-07 | Acadia Pharmaceuticals Inc. | PIMAVANSERIN FORMULATIONS |
| JP2024500404A (ja) * | 2020-12-18 | 2024-01-09 | キューイーディー セラピューティクス，インコーポレイテッド | 軟骨形成不全症の治療方法 |
| WO2022194941A1 (en) * | 2021-03-17 | 2022-09-22 | Actelion Pharmaceuticals Ltd | Pharmaceutical dosage system |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
| NZ591443A (en) | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
| BRPI0620408B8 (pt) | 2005-12-21 | 2021-05-25 | Novartis Ag | derivados de pirimidinil aril uréia sendo inibidores de fgf, seus usos, e preparação farmacêutica |
| FR2910813B1 (fr) * | 2006-12-28 | 2009-02-06 | Sanofi Aventis Sa | Nouvelle utilisation therapeutique pour le traitement des leucemies |
| AR079257A1 (es) * | 2009-12-07 | 2012-01-04 | Novartis Ag | Formas cristalinas de 3-(2,6-dicloro-3-5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas |
| AU2012279301A1 (en) | 2011-07-01 | 2014-01-09 | Novartis Ag | Combination therapy |
| AU2014287209B2 (en) | 2013-07-09 | 2019-01-24 | Dana-Farber Cancer Institute, Inc. | Kinase inhibitors for the treatment of disease |
| CN105813635A (zh) | 2013-12-13 | 2016-07-27 | 诺华股份有限公司 | 药物剂型 |
| EP3191127A1 (en) | 2014-09-13 | 2017-07-19 | Novartis AG | Combination therapies of egfr inhibitors |
| CN107787226A (zh) | 2015-03-25 | 2018-03-09 | 诺华股份有限公司 | 药物组合 |
| US10702527B2 (en) | 2015-06-12 | 2020-07-07 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
-
2014
- 2014-12-11 CN CN201480067964.6A patent/CN105813635A/zh active Pending
- 2014-12-11 PH PH1/2016/501039A patent/PH12016501039B1/en unknown
- 2014-12-11 PE PE2016000773A patent/PE20160851A1/es unknown
- 2014-12-11 NZ NZ760002A patent/NZ760002A/en unknown
- 2014-12-11 EP EP14819084.6A patent/EP3079667B1/en active Active
- 2014-12-11 MY MYPI2016701712A patent/MY194303A/en unknown
- 2014-12-11 AR ARP140104615A patent/AR098716A1/es not_active Application Discontinuation
- 2014-12-11 RS RSP20191178 patent/RS59270B1/sr unknown
- 2014-12-11 CN CN202310950714.8A patent/CN116942629A/zh active Pending
- 2014-12-11 DK DK14819084.6T patent/DK3079667T3/da active
- 2014-12-11 EA EA201691231A patent/EA036288B1/ru unknown
- 2014-12-11 LT LTEP14819084.6T patent/LT3079667T/lt unknown
- 2014-12-11 AU AU2014362999A patent/AU2014362999B2/en active Active
- 2014-12-11 EP EP19181217.1A patent/EP3597179B1/en active Active
- 2014-12-11 CA CA2930055A patent/CA2930055C/en active Active
- 2014-12-11 KR KR1020167015239A patent/KR102349893B1/ko active Active
- 2014-12-11 SG SG10202104627UA patent/SG10202104627UA/en unknown
- 2014-12-11 MX MX2016007652A patent/MX2016007652A/es active IP Right Grant
- 2014-12-11 WO PCT/IB2014/066820 patent/WO2015087283A1/en not_active Ceased
- 2014-12-11 NZ NZ719865A patent/NZ719865A/en unknown
- 2014-12-11 TN TN2016000207A patent/TN2016000207A1/en unknown
- 2014-12-11 MA MA39175A patent/MA39175A1/fr unknown
- 2014-12-11 JP JP2016538536A patent/JP6522619B2/ja active Active
- 2014-12-11 PT PT148190846T patent/PT3079667T/pt unknown
- 2014-12-11 SI SI201431315T patent/SI3079667T1/sl unknown
- 2014-12-11 HR HRP20191691TT patent/HRP20191691T1/hr unknown
- 2014-12-11 HU HUE14819084A patent/HUE045156T2/hu unknown
- 2014-12-11 ES ES14819084T patent/ES2745983T3/es active Active
- 2014-12-11 US US15/102,378 patent/US10278969B2/en active Active
- 2014-12-11 PL PL14819084T patent/PL3079667T3/pl unknown
- 2014-12-12 TW TW103143546A patent/TWI721938B/zh active
- 2014-12-12 TW TW109136485A patent/TWI800759B/zh active
-
2016
- 2016-05-06 ZA ZA2016/03064A patent/ZA201603064B/en unknown
- 2016-05-18 IL IL245705A patent/IL245705B/en active IP Right Grant
- 2016-06-10 CL CL2016001436A patent/CL2016001436A1/es unknown
- 2016-07-13 EC ECIEPI201660194A patent/ECSP16060194A/es unknown
-
2019
- 2019-03-26 US US16/364,727 patent/US11160804B2/en active Active
- 2019-04-23 JP JP2019082147A patent/JP6804585B2/ja active Active
- 2019-09-23 CY CY20191100999T patent/CY1122063T1/el unknown
-
2021
- 2021-09-29 US US17/489,382 patent/US20220265651A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI856111B (zh) | 一種含有布魯頓氏酪胺酸激酶抑制劑的口服固體錠劑及其製備方法 | |
| JP2017502941A5 (enExample) | ||
| KR101977785B1 (ko) | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법 | |
| JP2007091758A5 (enExample) | ||
| RU2019138248A (ru) | Фармацевтическая композиция для перорального введения, содержащая энзалутамид | |
| JP6320371B2 (ja) | エンテカビルの医薬組成物および製造方法 | |
| JP2016536285A (ja) | アムロジピン及びバルサルタンを含む安定な医薬組成物 | |
| JP2011500811A5 (enExample) | ||
| KR101171375B1 (ko) | 난용성 약물을 함유하는 경구 제형 | |
| KR102349893B1 (ko) | 제약 투여 형태 | |
| JPWO2011121823A1 (ja) | 経口投与用粒子状医薬組成物 | |
| CN102846573B (zh) | 水飞蓟宾双层缓释片及其制备方法 | |
| JP2013544272A5 (enExample) | ||
| JP2017520619A5 (enExample) | ||
| JP6379043B2 (ja) | カンデサルタンシレキセチル含有医薬組成物 | |
| KR20100046216A (ko) | 칸데사르탄의 약학 조성물 | |
| JP6883401B2 (ja) | アジルサルタン含有錠剤及び錠剤におけるアジルサルタンの安定化方法 | |
| JP2016124861A (ja) | オルメサルタンメドキソミル含有口腔内崩壊錠 | |
| CN112057427B (zh) | 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法 | |
| CN101152155A (zh) | 盐酸伊伐布雷定固体药物组合物及其制备方法 | |
| JP6176246B2 (ja) | 固形医薬錠剤およびその製造方法 | |
| WO2014122671A2 (en) | Solid oral compositions of saxagliptin | |
| CN104000821B (zh) | 含有替米沙坦和苯磺酸氨氯地平的口服双层片剂及其制备方法 | |
| CN100551369C (zh) | 一种含有西洛他唑的缓释制剂及其制备方法 | |
| JP6004882B2 (ja) | 圧縮成形に用いるためのマンニトール賦形剤及びこれを含有する錠剤 |